Anderson S G, Gilbert G L
Department of Microbiology/Infectious Diseases, Royal Children's Hospital, Parkville, Victoria, Australia.
J Paediatr Child Health. 1990 Aug;26(4):212-6. doi: 10.1111/j.1440-1754.1990.tb02432.x.
Twenty-four infants treated for neonatal Gram negative bacillary meningitis over a 10-year period were reviewed to determine the mortality and incidence of complications including relapse. Nine (37.5%) infants died; two survivors had major and 13 minimal or no handicap. Five (21%) infants had a relapse of meningitis after the initial course of treatment; two of these infants had been treated with cefotaxime. The outcome did not correlate with age, sex, gestation, cerebrospinal fluid (CSF) parameters or peripheral neutrophil counts. A poor outcome was associated with thrombocytopenia, persistence of viable organisms in the CSF for more than 24 h and with seizures, particularly in infants aged 7 days or less. There were no clinical or laboratory parameters predictive of subsequent relapse and there was no apparent relationship with choice or dose of antibiotic used or duration of treatment.
回顾了10年间接受新生儿革兰氏阴性杆菌脑膜炎治疗的24例婴儿,以确定死亡率和包括复发在内的并发症发生率。9例(37.5%)婴儿死亡;2例存活者有严重残疾,13例有轻微残疾或无残疾。5例(21%)婴儿在初始治疗疗程后发生脑膜炎复发;其中2例婴儿接受了头孢噻肟治疗。结局与年龄、性别、孕周、脑脊液(CSF)参数或外周中性粒细胞计数无关。不良结局与血小板减少、脑脊液中活菌持续存在超过24小时以及癫痫发作有关,尤其是7日龄及以下的婴儿。没有临床或实验室参数可预测随后的复发,且与所用抗生素的选择或剂量或治疗持续时间没有明显关系。